Eli Lilly And Novo Nordisk: Historic GLP-1 Pricing Deals - What You Need To Know (NVO)

Eli Lilly And Novo Nordisk: Historic GLP-1 Pricing Deals – What You Need To Know (NVO)

November 7, 2025

Novo Nordisk A/S & Eli Lilly and Company cut prices for top diabetes drugs, boosting accessibility and potential revenue. Click for my updated look at LLY and NVO.

Search

RECENT PRESS RELEASES

‘Environmental catastrophe’ fears as millions of plastic beads wash up on Camber Sands

SWI Editorial Staff2025-11-08T13:03:46-08:00November 8, 2025|

You Can Outperform Around 90% of Professional Fund Managers by Using This Simple Investmen

SWI Editorial Staff2025-11-08T13:02:15-08:00November 8, 2025|

How to spot non-infrastructure AI plays worth investing in

SWI Editorial Staff2025-11-08T13:01:44-08:00November 8, 2025|

Michael Burry’s Bets Against AI Stocks Nvidia and Palantir: What Investors Should Know

SWI Editorial Staff2025-11-08T13:01:22-08:00November 8, 2025|

Investing in Fonterra Co-operative Group (NZSE:FCG) three years ago would have delivered y

SWI Editorial Staff2025-11-08T13:00:44-08:00November 8, 2025|

SWI Editorial Staff2025-11-08T12:56:22-08:00November 8, 2025|